CaringKind Appoints New Board Members to Enhance Alzheimer's Care

CaringKind has appointed three new members to its Board of Directors, enhancing its proficiency in senior care, clinical research, and financial management. This strategic move comes as Alzheimer's disease impacts over 7 million Americans, with projections indicating this number could nearly double by 2060. The appointees, including Bal Agrawal of LifeWorx, Michael Ferik of Prosperity Life, and Sean Stanton of K2 Medical Research, will bolster CaringKind’s ability to meet increased demands in Alzheimer's care.

"These three leaders bring exactly the expertise CaringKind needs to meet this moment," remarked Eleonora Tornatore-Mikesh, President and CEO of CaringKind, underscoring the importance of their diverse expertise. The appointments coincide with the organization’s 30th Anniversary Forget-Me-Not Gala and the expansion of its 100 Women of Impact program. Sean Stanton expressed his commitment to CaringKind's mission, highlighting how the organization provides dignity and guidance to families affected by Alzheimer's.

With significant experience across various sectors, the new board members are poised to enhance CaringKind's operations. Bal Agrawal, with a rich background in senior care, has a personal and professional commitment to caregiving, contributing to organizations like the Alzheimer's Drug Discovery Foundation. Michael Ferik, managing over $29 billion in assets at Prosperity Life, offers extensive experience in financial operations and strategic growth. Sean Stanton, specializing in clinical research, emphasizes advancing Alzheimer's treatments and supporting affected families, drawing from his personal connection to the disease. For more details on CaringKind's services, visit wearecaringkind.org or call 646-744-2900.